Prognostic Effect of<i>BRAF</i>and<i>KRAS</i>Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab - Concepedia

Concepedia

Publication | Closed Access

Prognostic Effect of<i>BRAF</i>and<i>KRAS</i>Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab

145

Citations

54

References

2016

Year

Aziz Zaanan, Karine Le Malicot, Catherine Julié, Hélène Blons, Laurent Mineur, Jaafar Bennouna, Josep Tabernero, Enrico Mini, Gunnar Folprecht, Jean‐Luc Van Laethem,

Abstract

EudraCT 2005-003463-23.

References

	Year	Citations

Page 1